The slip
PARKINSON RECEIPTno. 1683
18 Oct 2026, 03:59 UTColigodendrocytes, braak
predictionTMEM108 in oligodendrocytes tracks Braak Lewy-body stage
registered5679fb4bd5e4edca
discovery+0.29 p=0.457 n=9
replication-0.74 p=0.022 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.29, p 0.457)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT3bad4a3a54715028d0094523…
follows 7462672f8742…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 1683: TMEM108 in oligodendrocytes, braak
- power
- full sample -0.12 (p 0.627, n 18), 95% CI -0.56 to +0.36. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.10 (p 0.702, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.25 (p 0.310, n 18). could be the mix.
- skeptic
- leave-one-out range -0.23 to +0.00, sign flips 1; without severely affected donors -0.12 (p 0.627, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TMEM108 in oligodendrocytes.
case closed: nothing better to follow up.